Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
64.4M
-
Number of holders
-
195
-
Total 13F shares, excl. options
-
67.9M
-
Shares change
-
-543K
-
Total reported value, excl. options
-
$838M
-
Value change
-
+$9.83M
-
Put/Call ratio
-
0.02
-
Number of buys
-
101
-
Number of sells
-
-92
-
Price
-
$12.35
Significant Holders of AVID BIOSERVICES, INC. - Common Stock, par value $0.001 per share (CDMO) as of Q4 2024
244 filings reported holding CDMO - AVID BIOSERVICES, INC. - Common Stock, par value $0.001 per share as of Q4 2024.
AVID BIOSERVICES, INC. - Common Stock, par value $0.001 per share (CDMO) has 195 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.9M shares
.
Largest 10 shareholders include BlackRock, Inc. (5.26M shares), AltraVue Capital, LLC (3.8M shares), VANGUARD GROUP INC (3.77M shares), GLAZER CAPITAL, LLC (3.72M shares), PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. (2.88M shares), STATE STREET CORP (2.67M shares), FIL Ltd (2.56M shares), Royal Bank of Canada (2.51M shares), GOLDMAN SACHS GROUP INC (1.95M shares), and ALPINE ASSOCIATES MANAGEMENT INC. (1.95M shares).
This table shows the top 195 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.